/주식/VIGL
VIGL

VIGL

USD

Vigil Neuroscience Inc. Common Stock

$7.870+0.000 (0.000%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$7.870

고가

$7.880

저가

$7.840

거래량

3.58M

기업 기본 정보

시가총액

367.3M

산업

생명공학

국가

United States

거래 통계

평균 거래량

1.10M

거래소

NMS

통화

USD

52주 범위

저가 $1.312현재가 $7.870고가 $7.95

관련 뉴스

PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

더 보기
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders
PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, TASK, VIGL on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

더 보기
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, TASK, VIGL on Behalf of Shareholders
PR Newswire

VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm

The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Vigil Neuroscience, Inc. ...

더 보기
VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm
GlobeNewswire

Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP

WATERTOWN, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative

더 보기
Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, AXL, SWTX, VIGL on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

더 보기
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, AXL, SWTX, VIGL on Behalf of Shareholders
Analyst Upgrades

Stifel Downgrades Vigil Neuroscience to Hold, Lowers Price Target to $8

Stifel analyst Paul Matteis downgrades Vigil Neuroscience from Buy to Hold and lowers the price target from $11 to $8.

Analyst Upgrades

HC Wainwright & Co. Downgrades Vigil Neuroscience to Neutral, Lowers Price Target to $8

HC Wainwright & Co. analyst Andrew Fein downgrades Vigil Neuroscience from Buy to Neutral and lowers the price target from $14 to $8.